THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $19,000 | +26.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $15,000 | +15.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -72.9% | 12,000 | -40.0% | 0.00% | -50.0% |
| Q4 2019 | $48,000 | -34.2% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $73,000 | +151.7% | 20,000 | +77.8% | 0.00% | +100.0% |
| Q2 2019 | $29,000 | -47.3% | 11,250 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $55,000 | -5.2% | 11,250 | -25.2% | 0.00% | -25.0% |
| Q4 2018 | $58,000 | -48.2% | 15,036 | -11.8% | 0.00% | -33.3% |
| Q3 2018 | $112,000 | +80.6% | 17,041 | +70.4% | 0.01% | +50.0% |
| Q2 2018 | $62,000 | +26.5% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $49,000 | -18.3% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $60,000 | +13.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $53,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $53,000 | -26.4% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $72,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
| Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
| 1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
| SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
| MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
| Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
| STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
| Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
| GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |